The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Immunological and Toxicological Considerations for the Design of Liposomes
Open accessAbstract
Liposomes hold great potential as gene and drug delivery vehicles due to their biocompatibility and modular properties, coupled with the major advantage of attenuating the risk of systemic toxicity from the encapsulated therapeutic agent. Decades of research have been dedicated to studying and optimizing liposomal formulations for a variety of medical applications, ranging from cancer therapeutics to analgesics. Some effort has also been made to elucidate the toxicities and immune responses that these drug formulations may elicit. Notably, intravenously injected liposomes can interact with plasma proteins, leading to opsonization, thereby altering the healthy cells they come into contact with during circulation and removal. Additionally, due to the pharmacokinetics of liposomes in circulation, drugs can end up sequestered in organs of the mononuclear phagocyte system, affecting liver and spleen function. Importantly, liposomal agents can also stimulate or suppress the immune system depending on their physiochemical properties, such as size, lipid composition, pegylation, and surface charge. Despite the surge in the clinical use of liposomal agents since 1995, there are still several drawbacks that limit their range of applications. This review presents a focused analysis of these limitations, with an emphasis on toxicity to healthy tissues and unfavorable immune responses, to shed light on key considerations that should be factored into the design and clinical use of liposomal formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“The reprogramming of classically activated (M1) TAMs, which have a role in eradicating tumor cells in their early stages, to alternatively activated M2‐like TAMs has been shown to promote tumor growth and metastasis, as shown in Figure 2 [110,111].”
BackgroundRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Liposomal encapsulated drugs first reached the clinic in 1995 with the US Food and Drug Administration (FDA)-approval of Doxil (liposomal doxorubicin) for the treatment of AIDS-related Kaposi′s sarcoma, and Doxil was later approved to treat ovarian cancer and multiple myeloma [7].”
BackgroundDiffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“Since their discovery by Alec Bangham in the 1960s [5,6], liposomes have been studied extensively as drug delivery vehicles due to their capacity to load both hydrophilic and hydrophobic agents, as well as their high biocompatibility and tunable size, charge, and surface properties [1–4].”
BackgroundLiposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, E., Tussiwand, R., & Yona, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3712 · Cited by 1,819
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
Lovell, J. F., Jin, C. S., Huynh, E., Jin, H., Kim, C., Rubinstein, J. L., Chan, W. C. W., Cao, W., Wang, L. V., & Zheng, G. (2011) · Nature Materials · doi:10.1038/nmat2986 · Cited by 1,362
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., & McNeil, S. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800032f · Cited by 1,022
A review on phospholipids and their main applications in drug delivery systems
Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.09.004 · Cited by 1,003
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864 · cited 3×
“, C3a, C4a, C5a) (Figure 3) [137,148].”
BackgroundInfluence of cholesterol on liposome stability and on in vitro drug release
Briuglia, M.-L., Rotella, C., McFarlane, A., & Lamprou, D. A. (2015) · Drug Delivery and Translational Research · doi:10.1007/s13346-015-0220-8 · Cited by 740
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Tabernero, J., Shapiro, G. I., LoRusso, P. M., Cervantes, A., Schwartz, G. K., Weiss, G. J., Paz-Ares, L., Cho, D. C., Infante, J. R., Alsina, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0429 · Cited by 698
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Lipid-based Nanoparticles for Nucleic Acid Delivery
Li, W., & Szoka, F. C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9180-5 · Cited by 641
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Liposomal Drug Delivery Systems and Anticancer Drugs
Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 603
Role of natural and immune IgM antibodies in immune responses
Boes, M. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(01)00025-6 · Cited by 602
Castells, M. C., Tennant, N. M., Sloane, D. E., Ida Hsu, F., Barrett, N. A., Hong, D. I., Laidlaw, T. M., Legere, H. J., Nallamshetty, S. N., Palis, R. I., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.044 · Cited by 600
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Kirby, C., Clarke, J., & Gregoriadis, G. (1980) · Biochemical Journal · doi:10.1042/bj1860591 · Cited by 592
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Hammerschmidt, D., Hudson, L., Weaver, L. J., Craddock, P., & Jacob, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91403-8 · Cited by 556
Kedmi, R., Ben-Arie, N., & Peer, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.027 · Cited by 546 · cited 3×
“Cationic liposomes also increased the amount of Th1 and Th17 cytokines by 10–24 fold at 2 h post‐injection [80].”
BackgroundPEGylated liposomes: immunological responses
Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 523
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Nonviral delivery of synthetic siRNAs in vivo
Akhtar, S., & Benter, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33494 · Cited by 464
Liposomes for use in gene delivery
Balazs, D. A., & Godbey, W. (2011) · Journal of Drug Delivery · doi:10.1155/2011/326497 · Cited by 441
Filion, M. C., & Phillips, N. C. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00126-0 · Cited by 428
Vieira, D., & Gamarra, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117210 · Cited by 427
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Li, Y., Schwabe, R. F., DeVries-Seimon, T., Yao, P. M., Gerbod-Giannone, M.-C., Tall, A. R., Davis, R. J., Flavell, R., Brenner, D. A., & Tabas, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501759200 · Cited by 421
Wang, X., Ishida, T., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.010 · Cited by 421
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 380
Exposure of platelet membrane phosphatidylserine regulates blood coagulation
Lentz, B. R. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00025-0 · Cited by 371
Yang, Q., Jacobs, T. M., McCallen, J. D., Moore, D. T., Huckaby, J. T., Edelstein, J. N., & Lai, S. K. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03437 · Cited by 370
Chonn, A., Cullis, P. R., & Devine, D. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4234 · Cited by 367
Hadjidemetriou, M., Al-Ahmady, Z., Mazza, M., Collins, R. F., Dawson, K., & Kostarelos, K. (2015) · ACS Nano · doi:10.1021/acsnano.5b03300 · Cited by 358
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
In vivo toxicity of cationic micelles and liposomes
Knudsen, K. B., Northeved, H., Kumar EK, P., Permin, A., Gjetting, T., Andresen, T. L., Larsen, S., Wegener, K. M., Lykkesfeldt, J., Jantzen, K., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.08.004 · Cited by 356
Permeability properties of phospholipid membranes: Effect of cholesterol and temperature
Papahadjopoulos, D., Nir, S., & Ohki, S. (1972) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(72)90354-9 · Cited by 355
Liposomes as carriers of antigens and adjuvants
Alving, C. R. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90120-5 · Cited by 344
Questioning the use of PEGylation for drug delivery
Verhoef, J. J. F., & Anchordoquy, T. J. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0176-5 · Cited by 342
Papahadjopoulos, D., Cowden, M., & Kimelberg, H. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90280-0 · Cited by 336
Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes
López-Pinto, J. M., González-Rodríguez, M. L., & Rabasco, A. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.021 · Cited by 335
Lipid–Drug Conjugate for Enhancing Drug Delivery
Irby, D., Du, C., & Li, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01027 · Cited by 331
Smaby, J. M., Momsen, M. M., Brockman, H. L., & Brown, R. E. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78181-5 · Cited by 329
Accelerated clearance of PEGylated liposomes in rats after repeated injections
Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327
Gubernator, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.566552 · Cited by 325
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2003.10.004 · Cited by 312
Wei, X., Shao, B., He, Z., Ye, T., Luo, M., Sang, Y., Liang, X., Wang, W., Luo, S., Yang, S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.9 · Cited by 306
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Mond, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80109-x · Cited by 288
Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 287
Cationic liposomes for gene delivery
Simões, S., Filipe, A., Faneca, H., Mano, M., Penacho, N., Düzgünes, N., & Pedroso de Lima, M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.237 · Cited by 285
Harashima, H., Sakata, K., Funato, K., & Kiwada, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018965121222 · Cited by 284
Tsui, F. C., Ojcius, D. M., & Hubbell, W. L. (1986) · Biophysical Journal · doi:10.1016/s0006-3495(86)83655-4 · Cited by 282
Li, Y., Ge, M., Ciani, L., Kuriakose, G., Westover, E. J., Dura, M., Covey, D. F., Freed, J. H., Maxfield, F. R., Lytton, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405195200 · Cited by 282
Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280
Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.
Rahman, A. M., Yusuf, S. W., & Ewer, M. S. (2007) · PubMed Central · Cited by 267
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.10.001 · Cited by 263
Vascular Targeting in Photodynamic Occlusion of Subretinal Vessels
Schmidt-Erfurth, U., Hasan, T., Gragoudas, E., Michaud, N., Flotte, T. J., & Birngruber, R. (1994) · Ophthalmology · doi:10.1016/s0161-6420(13)31079-3 · Cited by 251
Immune response in biocompatibility
Remes, A., & Williams, D. F. (1992) · Biomaterials · doi:10.1016/0142-9612(92)90010-l · Cited by 251
Caracciolo, G. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.11.003 · Cited by 246
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Khang, D., Lee, Y. K., Choi, E.-J., Webster, T. J., & Kim, S.-H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72998 · Cited by 244
Functional groups on polystyrene model nanoparticles: Influence on protein adsorption
Gessner, A., Lieske, A., Paulke, B., & Müller, R. H. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10371 · Cited by 239
Papahadjopoulos, D., Poste, G., & Schaeffer, B. E. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90429-x · Cited by 239
Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes
Lappalainen, K., Jääskeläinen, I., Syrjänen, K., Urtti, A., & Syrjänen, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018932714745 · Cited by 238
Intracellular Distribution and Mechanism of Delivery of Oligonucleotides Mediated by Cationic Lipids
Zelphati, O., & Szoka, F. C. (1996) · Pharmaceutical Research · doi:10.1023/a:1016026101195 · Cited by 230
Szebeni, J., Bedőcs, P., Rozsnyay, Z., Weiszhár, Z., Urbanics, R., Rosivall, L., Cohen, R., Garbuzenko, O., Báthori, G., Tóth, M., et al. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.003 · Cited by 219
Cholesterol level affects surface charge of lipid membranes in saline solution
Magarkar, A., Dhawan, V., Kallinteri, P., Viitala, T., Elmowafy, M., Róg, T., & Bunker, A. (2014) · Scientific Reports · doi:10.1038/srep05005 · Cited by 218
Bhakay, A., Rahman, M., Dave, R. N., & Bilgili, E. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030086 · Cited by 215
Kozma, G. T., Mészáros, T., Vashegyi, I., Fülöp, T., Örfi, E., Dézsi, L., Rosivall, L., Bavli, Y., Urbanics, R., Mollnes, T. E., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b03942 · Cited by 214
Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004790 · Cited by 212
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
The Current State of Nanoparticle-Induced Macrophage Polarization and Reprogramming Research
Miao, X., Leng, X., & Zhang, Q. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020336 · Cited by 211
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K.-T., Burnett, J., & Rossi, J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 205
Roadmap and strategy for overcoming infusion reactions to nanomedicines
Szebeni, J., Simberg, D., González-Fernández, Á., Barenholz, Y., & Dobrovolskaia, M. A. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0273-1 · Cited by 205
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Van Rooijen, N., & Sanders, A. (1996) · Hepatology · doi:10.1002/hep.510230544 · Cited by 188
DEMEL, R. A., Kinsky, S. C., Kinsky, C. B., & Deenen, L. L. M. V. (1968) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(68)90055-2 · Cited by 184
Alberts, D. S., & Garcia, D. J. (1997) · Drugs · doi:10.2165/00003495-199700544-00007 · Cited by 182
Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten
Kinsky, S. C., Haxby, J. A., Zopf, D. A., Alving, C. R., & Kinsky, C. B. (1969) · Biochemistry · doi:10.1021/bi00838a036 · Cited by 182
Correlation of the cytotoxic effects of cationic lipids with their headgroups
Cui, S., Wang, Y., Gong, Y., Lin, X., Zhao, Y., Zhi, D., Zhou, Q., & Zhang, S. (2018) · Toxicology Research · doi:10.1039/c8tx00005k · Cited by 179
Szebeni, J., Fontana, J. L., Wassef, N. M., Mongan, P. D., Morse, D. S., Dobbins, D. E., Stahl, G. L., Bünger, R., & Alving, C. R. (1999) · Circulation · doi:10.1161/01.cir.99.17.2302 · Cited by 176
Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D. S., Basta, M., Stahl, G. L., Bünger, R., & Alving, C. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1319 · Cited by 171
Bressler, N. M. (2001) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · Cited by 170
Remote loading of preencapsulated drugs into stealth liposomes
Sur, S., Fries, A. C., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324135111 · Cited by 169
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
Ichihara, M., Shimizu, T., Imoto, A., Hashiguchi, Y., Uehara, Y., Ishida, T., & Kiwada, H. (2010) · Pharmaceutics · doi:10.3390/pharmaceutics3010001 · Cited by 168
Designer lipids for drug delivery: From heads to tails
Kohli, A. G., Kierstead, P. H., Venditto, V. J., Walsh, C. L., & Szoka, F. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.047 · Cited by 167
From the Reticuloendothelial to Mononuclear Phagocyte System – The Unaccounted Years
Yona, S., & Gordon, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00328 · Cited by 164
“In Vivo” Depletion of Macrophages by Liposome-Mediated “Suicide”
Rooijen, N. V., & Kesteren-Hendrikx, E. V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)73001-8 · Cited by 164
Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model
Soenen, S. J. H., Brisson, A. R., & De Cuyper, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.040 · Cited by 162
Luo, D., Li, N., Carter, K. A., Lin, C., Geng, J., Shao, S., Huang, W., Qin, Y., Atilla‐Gokcumen, G. E., & Lovell, J. F. (2016) · Small · doi:10.1002/smll.201503966 · Cited by 162
Fan, Y., Sahdev, P., Ochyl, L. J., J. Akerberg, J., & Moon, J. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.010 · Cited by 159
Xing, M., Yan, F., Yu, S., & Shen, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133569 · Cited by 157
Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 157
Daemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 148
Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgM
Cheng, T., Wu, P.-Y., Wu, M., Chern, J., & Roffler, S. R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980143z · Cited by 147
Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions
Szebeni, J., & Moghimi, S. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100902792855 · Cited by 145
Soundararajan, A., Bao, A., Phillips, W. T., Perez, R., & Goins, B. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.02.004 · Cited by 145
Designing liposomal adjuvants for the next generation of vaccines
Perrie, Y., Crofts, F., Devitt, A., Griffiths, H. R., Kastner, E., & Nadella, V. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.005 · Cited by 140
Toxicity screening of liposomes
Parnham, M. J., & Wetzig, H. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90070-j · Cited by 137
van den Berg, R. H., Faber‐Krol, M. C., Sim, R. B., & Daha, M. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6924 · Cited by 130
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
Interaction of phospholipid vesicles with cultured mammalian cells
Pagano, R. E., Huang, L., & Wey, C. (1974) · Nature · doi:10.1038/252166a0 · Cited by 126
Ishida, T., Kashima, S., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.009 · Cited by 125
The Interaction of Liposomes with the Complement System
Szebeni, J. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i1.20 · Cited by 123
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
Alving, C. R., Rao, M., Steers, N. J., Matyas, G. R., & Mayorov, A. V. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.35 · Cited by 122
Henriksen‐Lacey, M., Devitt, A., & Perrie, Y. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.019 · Cited by 118
Characteristics and biodistribution of cationic liposomes and their DNA complexes
Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H., & Kitagawa, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00293-5 · Cited by 117
Ishida, T., Ichikawa, T., Ichihara, M., Sadzuka, Y., & Kiwada, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 117
Heath, T. D., Lopez, N. G., & Papahadjopoulos, D. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90217-2 · Cited by 117
Romøren, K., Thu, B. J., Bols, N. C., & Evensen, Ø. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.02.007 · Cited by 112
Liposome toxicity in the mouse central nervous system
Adams, D., Joyce, G., Richardson, V. J., et al. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90104-6 · Cited by 111
Gabizón, A., Isacson, R., Rosengarten, O. S., Tzemach, D., Shmeeda, H., & Sapir, R. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0525-5 · Cited by 110
Induction of apoptosis in macrophages by cationic liposomes
Aramaki, Y., Takano, S., & Tsuchiya, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01386-1 · Cited by 108
Effects of the protein corona on liposome–liposome and liposome–cell interactions
Tasciotti, E., Molinaro, R., Taraballi, F., Furman, N. E. T., Sherman, M. B., Parodi, A., Salvatore, F., & Corbo, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s109059 · Cited by 108
Hamilton, A. L., Biganzoli, L., Coleman, R. E., Mauriac, L., Hennebert, P., Awada, A. H., Nooij, M., Beex, L. V. A. M., Piccart, M. J., Hoorebeeck, I. V., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf157 · Cited by 105
Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes
Nunes, S. S., Fernandes, R. S., Cavalcante, C. H., César, I. C., Leite, E. A., Lopes, S. C. A., Ferretti, A., Rubello, D., Townsend, D. M., Oliveira, M. C., et al. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0583-8 · Cited by 103
Mechanisms of light‐induced liposome permeabilization
Miranda, D., & Lovell, J. F. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10032 · Cited by 101
The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
Kimelberg, H. K., Tracy, T. F., Biddlecome, S. M., & BOURKE, R. S. (1976) · PubMed · Cited by 99
Allen, T. M., Murray, L., MacKeigan, S., & Shah, M. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21855-9 · Cited by 97
Iwaoka, S., Nakamura, T., Takano, S., Tsuchiya, S., & Aramaki, Y. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405181 · Cited by 92
Badiee, A., Khamesipour, A., Samiei, A., Soroush, D., Shargh, V. H., Kheiri, M. T., Barkhordari, F., Master, W. R. M., Mahboudi, F., & Jaafari, M. R. (2012) · Experimental Parasitology · doi:10.1016/j.exppara.2012.09.001 · Cited by 91
Takano, S., Aramaki, Y., & Tsuchiya, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1024441702398 · Cited by 87
Rajan, R., Sabnani, M. K., Mavinkurve, V., Shmeeda, H., Mansouri, H., Bonkoungou, S., Le, A. D., Wood, L. M., Gabizón, A., & La-Beck, N. M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.023 · Cited by 79
Temporal progression of the host response to implanted poly(ethylene glycol)‐based hydrogels
Lynn, A. D., Blakney, A. K., Kyriakides, T. R., & Bryant, S. J. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33015 · Cited by 77
Complement activation by PEGylated liposomes containing prednisolone
van den Hoven, J. M., Nemes, R., Metselaar, J. M., Nuijen, B., Beijnen, J. H., Storm, G., & Szebeni, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.03.007 · Cited by 74
Arnold, R. D., Mager, D. E., Slack, J. E., & Straubinger, R. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1365 · Cited by 69
Luo, R., Li, Y., He, M., Zhang, H., Yuan, H., Johnson, M. T., Palmisano, M., Zhou, S. Y., & Sun, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.002 · Cited by 69
Kanter, P. M., Bullard, G. A., Pilkiewicz, F. G., Mayer, L. D., Cullis, P. R., & Pavelic, Z. P. (1993) · PubMed · Cited by 68
Reversible depression of the reticuloendothelial system by liposomes
Ellens, H. M., Mayhew, E. G., & Rustum, Y. M. (1982) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(82)90157-x · Cited by 66
Pharmacokinetics of lipid-drug conjugates loaded into liposomes
Signorell, R. D., Luciani, P., Brambilla, D., & Leroux, J. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.003 · Cited by 66
La-Beck, N. M., Liu, X., & Wood, L. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00220 · Cited by 65
Sellins, K. S., Fradkin, L. G., Liggitt, D., & DOW, S. W. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.008 · Cited by 64
Xu, H., Ye, F., Hu, M., Yin, P., Zhang, W., Li, Y., Xiu, Y., & Deng, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.885998 · Cited by 64
Storm, G., ten Kate, M. T., Working, P. K., & Bakker‐Woudenberg, I. A. J. M. (1998) · PubMed · Cited by 64
Bradley, A. J., Brooks, D. E., Norris-Jones, R., & Devine, D. V. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00013-9 · Cited by 62
Beyer, I., Cao, H., Persson, J., Song, H., Richter, M., Feng, Q., Yumul, R., van Rensburg, R., Li, Z., BERENSON, R. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3213 · Cited by 62
Toxicity of doxorubicin entrapped within long-circulating liposomes
Daemen, T., Regts, J., Meesters, M., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01501-5 · Cited by 61
Baglo, Y., Liang, B. J., Robey, R. W., Ambudkar, S. V., Gottesman, M. M., & Huang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.037 · Cited by 61
Self-citationCationic Liposomes Induce Macrophage Apoptosis through Mitochondrial Pathway
Aramaki, Y., Takano, S., & Tsuchiya, S. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2458 · Cited by 58
Fülöp, T., Kozma, G. T., Vashegyi, I., Mészáros, T., Rosivall, L., Urbanics, R., Storm, G., Metselaar, J. M., & Szebeni, J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.005 · Cited by 56
Effects of the anaphylatoxins on circulation
Marceau, F., Lundberg, C., & Hugli, T. E. (1987) · Immunopharmacology · doi:10.1016/0162-3109(87)90031-2 · Cited by 51
Badiee, A., Jaafari, M. R., Khamesipour, A., Samiei, A., Soroush, D., Kheiri, M. T., Barkhordari, F., McMaster, W. R., & Mahboudi, F. (2009) · Experimental Parasitology · doi:10.1016/j.exppara.2008.12.015 · Cited by 48
Allergic reactions and other rare side-effects of liposomal amphotericin
Ringdén, O. T. H., Andström, E. E., Remberger, M., Svahn, B. ‐., & Tollemar, J. G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90663-7 · Cited by 47
Hattori, Y., Shimizu, S., Ozaki, K., & Onishi, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040181 · Cited by 39
Roerdink, F. H., Regts, J., Handel, T. M., et al. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90404-5 · Cited by 38
Yang, K., Lü, Y., Xie, F., Zou, H. L., Fan, X., Li, B., Li, W., Zhang, W., Mei, L., Feng, S., et al. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0289 · Cited by 38
Wang, F., Ye, X., Wu, Y., Wang, H., Sheng, C., Peng, D., & Chen, W. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.10.027 · Cited by 36
Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia
Arning, M., Heer‐Sonderhoff, A. H., Wehmeier, A., & Schneider, W. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02112616 · Cited by 34
Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy
Inglut, C. T., Baglo, Y., Liang, B. J., Cheema, Y., Stabile, J., Woodworth, G. F., & Huang, H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091269 · Cited by 26
Self-citationCruz‐Leal, Y., Laurindo, M. F. L., Osugui, L., Luzardo, M. D. C., López‐Requena, A., Alonso, M. E., Álvarez, C., Popi, A. F., Mariano, M., Pérez, R., et al. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.01.006 · Cited by 18
Oro, S., Pham‐Ledard, A., Brice, P., Lebrun‐Vignes, B., Zehou, O., Reitter, D., Ram‐Wolff, C., Dupin, N., Bagot, M., Chosidow, O., et al. (2017) · European Journal of Dermatology · doi:10.1684/ejd.2017.2986 · Cited by 18
The effect of cholesterol in a liposomal Muc1 vaccine
Batenjany, M. M., Boni, L. T., Guo, Y., Neville, M. E., Bansal, S., Robb, R. J., & Popescu, M. C. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00383-2 · Cited by 14
Lopes, T. C. M., Silva, D. F., Costa, W. C., Frézard, F., Barichello, J. M., Silva-Barcellos, N. M., de Lima, W. G., & Rezende, S. A. (2018) · Pathology Research International · doi:10.1155/2018/9076723 · Cited by 12
Wang, F., Wang, H. H., Wu, Y., Wang, L., Zhang, L., Ye, X., Peng, D., & Chen, W. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.086769 · Cited by 12
Advancing photodynamic therapy with biochemically tuned liposomal nanotechnologies
Huang, H., Mallidi, S., Obaid, G., Sears, B., Tangutoori, S., & Hasan, T. G. (2015) · Elsevier eBooks · doi:10.1533/9781908818782.487 · Cited by 5
Self-citation
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 718
Overcoming skin barriers through advanced transdermal drug delivery approaches
Phatale, V., Vaiphei, K. K., Jha, S., Patil, D., Agrawal, M., & Alexander, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.025 · Cited by 482
Németh, Z., Csóka, I., Semnani Jazani, R., Sipos, B., Haspel, H., Kozma, G., Kónya, Z., & Dobó, D. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091798 · Cited by 452
Metadata
- Authors
- Inglut, C. T., Sorrin, A. J., Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H., & Huang, H.-C.
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2020-01-22
- Volume
- 10
- Issue
- 2
- Pages
- 190
- ISSN
- 2079-4991 (ISSN-L)
- OpenAlex
- W3001824115
- Cited by
- 371
- References
- 180
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.